Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring

WASSERBAUER, M., HLAVA, S., DRÁBEK, J., ŠŤOVÍČEK, J., MINAŘÍKOVÁ, P., NEDBALOVÁ, L., DRASAR, T., ZADOROVÁ, Z., DOLINA, J., KONEČNÝ, S., KOJECKY, V., KOŽELUHOVÁ, J., ČERNÍKOVÁ, P., PICHLEROVÁ, D., KUČEROVÁ, B., COUFAL, Štěpán, KEIL, R. Adalimumab biosimilars in the therapy of Crohn´s disease and ulcerative colitis: Prospective multicentric clinical monitoring. PLoS ONE. 2022, 17(8 August), e0271299. ISSN 1932-6203. E-ISSN 1932-6203. Available: doi: 10.1371/journal.pone.0271299.